DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trivaris (Triamcinolone Acetonide Intravitreal) - Published Studies

 
 



Trivaris Related Published Studies

Well-designed clinical trials related to Trivaris (Triamcinolone Intravitreal)

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study. [2011.11.23]

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. [2011.06]

Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. [2011.05]

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. [2011.04]

Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone. [2011.03]

Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. [2011.02]

Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema. [2011]

Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. [2011]

Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone. [2011]

Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. [2010.08]

Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. [2010.07]

Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification. [2010.06]

Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. [2010.05]

Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study. [2010.04]

Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. [2010.04]

Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. [2010.04]

Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. [2010.02]

Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. [2010]

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. [2009.12]

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. [2009.12]

Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. [2009.12]

Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. [2009.11]

Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial. [2009.11]

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. [2009.09]

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. [2009.09]

Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. [2009.09]

Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone. [2009.08]

Efficacy of intravitreal triamcinolone after or concomitant with laser photocoagulation in nonproliferative diabetic retinopathy with macular edema. [2009.07]

Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema. [2009.06]

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. [2009.06]

Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. [2009.05]

Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. [2009.04]

The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic anterior ischemic optic neuropathy. [2009.03]

Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis. [2009.03]

Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. [2009.02]

[ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD] [2009.01]

[ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD] [2009.01]

Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema. [2008.12.31]

Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. [2008.11]

Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema. [2008.11]

Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. [2008.11]

Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy. [2008.10]

Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial. [2008.10]

Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study. [2008.10]

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. [2008.09]

Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study. [2008.08]

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. [2008.07]

Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. [2008.07]

Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg. [2008.06]

Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema. [2008.06]

Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. [2008.04]

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. [2008.03]

Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. [2008.02]

A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. [2008.02]

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). [2008.01]

Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. [2007.12]

Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): design issues and implications. [2007.12]

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. [2007.12]

Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results. [2007.11]

Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. [2007.11]

Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. [2007.10]

Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection. [2007.09]

Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. [2007.09]

[Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration.] [2007.07]

Diabetic macular edema before and after intravitreal triamcinolone injection. [2007.06]

The effect of intravitreal triamcinolone on intraocular pressure. [2007.06]

A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema. [2007.02]

Well-designed clinical trials possibly related to Trivaris (Triamcinolone Intravitreal)

Evaluation of masking study participants to intravitreal injections in a randomized clinical trial. [2012]

SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. [2011.07]

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. [2011.02]

Steroids and macular edema from retinal vein occlusion. [2010.11.11]

A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. [2010.10]

Use of antivascular endothelial growth factor for diabetic macular edema. [2010.05.25]

Classification and treatment of radiation maculopathy. [2010.05]

Visual outcomes in five different approaches for treatment of central retinal vein occlusion. [2010.03]

NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. [2010.02]

SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. [2009.11]

SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type. [2009.04]

Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. [2009.01.21]

ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema. [2008.05]

Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. [2008.03]

Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. [2007.10.17]

The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. [2007.10]

Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. [2007.06]

Other research related to Trivaris (Triamcinolone Intravitreal)

Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial. [2014]

Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials. [2014]

Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion. [2014]

Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion. [2014]

A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protocol for a randomised controlled trial. [2013]

Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. [2013]

Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. [2012]

Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. [2012]

Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. [2012]

Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes. [2012]

Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. [2011.12.01]

Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. [2011.11]

Vitreous Pharmacokinetics and Retinal Safety of Intravitreal Preserved Versus Non-preserved Triamcinolone Acetonide in Rabbit Eyes. [2011.10.26]

Comparison of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial. [2011.10.12]

[Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD) treated with transpupillary thermotherapy (TTT) alone and with transpupillary thermotherapy (TTT) combined with injection of triamcinolone acetonide (sTTA) under posterior Tenon's capsule]. [2011]

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study. [2011]

Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. [2011]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017